微模拟洞察力,以了解抗喘糖素的功能和机制
Jian-Hong Qi1, Dong-Chuan Xu2, Xiao-Long Wang3,2,3
1Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
Frontiers in pharmacology
|September 15, 2023
概括
甘油显示出作为喘治疗的潜力,通过准转基林-2并形成纳米药物输送系统. 它与萨尔布塔摩尔的协同作用增强了抗喘活性,为临床应用铺平了道路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 喘是一种慢性呼吸道疾病,其特点是炎症和气道狭窄.
- 目前的治疗方法可能有局限性,需要寻找新的治疗药物.
- 已确定Transgelin-2作为喘治疗的潜在分子标.
研究的目的:
- 识别和评估甘油素作为一种潜在的抗喘化合物,准转基林-2.
- 为了研究甘油的抗喘作用背后的分子机制.
- 探索糖和沙布塔摩尔在喘治疗中的协同作用.
主要方法:
- 使用分子对接来识别化合物的虚拟选.
- 模拟分子动力学以评估复杂的稳定性和相互作用.
- 自组装模拟,以了解纳米药物输送系统的形成.
- 网络药理学用于预测分子机制.
主要成果:
- 甘油被确定为一种具有抗炎,抗氧化和抗喘特性的化合物,其向的是转基林-2.
- 分子动力学证实了甘油-转基林-2复合物的稳定性,突出了水友性域在准中的作用.
- 自组装模拟揭示了结合和疏水性相互作用是糖素纳米系统形成的关键驱动因素.
- 研究人员阐明了甘油和盐醇之间的协同效应,包括通过结和疏水相互作用对甘油纳米系统的坚持.
- 网络药理学预测了支持甘油的抗喘功效的分子机制.
结论:
- 甘酸显示出作为一种喘治疗剂的显著潜力,其向的是转基林-2.
- 甘油的自组装特性使得纳米药物输送系统的形成成为可能.
- 甘氨酸与沙尔布塔摩尔具有协同作用,通过向性传递机制增强抗喘活性.
- 这些发现为治疗喘时使用甘油的临床转化提供了坚实的基础.
相关概念视频
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Methylxanthines
266
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
266
Antiasthma Drugs: Leukotriene Modifiers
343
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
343
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
295
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
295


